Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171821
Status:
COMPLETED
Last Update Posted:
2020-02-11
First Post:
2005-09-13
Brief Title:
A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Study Overview
Official Title:
A One Year Open-label Single-arm Multi-center Trial Evaluating the Efficacy and Safety of Oral ICL670 20 mgkgDay in Patients Diagnosed With Transfusion-dependent Iron Overload
Status:
COMPLETED
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study uses a single arm multi-center open-label trial design The study will assess the efficacy and safety of 52 weeks of treatment with deferasirox ICL670 in patients with evidence of transfusion induced iron overload
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-003953-16 | EUDRACT_NUMBER | None | None |